ScoreWhy is Swedish Orphan Biovitrum AB ?
1
Healthy long term growth as Net Sales has grown by an annual rate of 12.34%
2
Positive results in Jun 25
- PRE-TAX PROFIT(Q) At SEK 1,031 MM has Grown at 238.03%
- NET PROFIT(Q) At SEK 825.24 MM has Grown at 232.17%
- DEBT-EQUITY RATIO (HY) Lowest at 30.09 %
3
With ROE of 11.90%, it has a attractive valuation with a 2.75 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 7.73%, its profits have risen by 102.5% ; the PEG ratio of the company is 0.2
4
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Swedish Orphan Biovitrum AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Swedish Orphan Biovitrum AB for you?
Low Risk, High Return
Absolute
Risk Adjusted
Volatility
Swedish Orphan Biovitrum AB
12.75%
69.23
27.57%
OMX Stockholm 30
8.01%
0.51
18.11%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.34%
EBIT Growth (5y)
8.66%
EBIT to Interest (avg)
6.87
Debt to EBITDA (avg)
1.73
Net Debt to Equity (avg)
0.33
Sales to Capital Employed (avg)
0.45
Tax Ratio
12.54%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.02%
ROE (avg)
10.77%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
2.75
EV to EBIT
18.51
EV to EBITDA
11.77
EV to Capital Employed
2.36
EV to Sales
4.42
PEG Ratio
0.23
Dividend Yield
NA
ROCE (Latest)
12.73%
ROE (Latest)
11.90%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
PRE-TAX PROFIT(Q)
At SEK 1,031 MM has Grown at 238.03%
NET PROFIT(Q)
At SEK 825.24 MM has Grown at 232.17%
DEBT-EQUITY RATIO
(HY)
Lowest at 30.09 %
RAW MATERIAL COST(Y)
Fallen by -5.21% (YoY
CASH AND EQV(HY)
Highest at SEK 2,055 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 2.34%
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Swedish Orphan Biovitrum AB
Pre-Tax Profit
At SEK 1,031 MM has Grown at 238.03%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (SEK MM)
Net Profit
At SEK 825.24 MM has Grown at 232.17%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (SEK MM)
Debt-Equity Ratio
Lowest at 30.09 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Cash and Eqv
Highest at SEK 2,055 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 2.34%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -5.21% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
